{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T22:13:54Z","timestamp":1791843234711,"version":"4.3.4"},"reference-count":132,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcehepatology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical and Experimental Hepatology"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.jceh.2022.06.005","type":"journal-article","created":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T12:03:08Z","timestamp":1656331388000},"page":"162-177","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Sarcopenia in the Cirrhotic Patient: Current Knowledge and Future Directions"],"prefix":"10.1016","volume":"13","author":[{"given":"Edgewood R.","family":"Warner II","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjaya K.","family":"Satapathy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jceh.2022.06.005_bib1","first-page":"177","article-title":"Clinical definition of sarcopenia","volume":"11","author":"Santilli","year":"2014","journal-title":"Clin Cases Miner Bone Metab"},{"key":"10.1016\/j.jceh.2022.06.005_bib2","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/ageing\/afy169","article-title":"Sarcopenia: revised European consensus on definition and diagnosis","volume":"48","author":"Cruz-Jentoft","year":"2019","journal-title":"Age Ageing"},{"key":"10.1016\/j.jceh.2022.06.005_bib3","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s00223-013-9830-7","article-title":"Total and appendicular lean mass reference ranges for Australian men and womenL the Geelong osteoporosis study","volume":"94","author":"Gould","year":"2014","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.jceh.2022.06.005_bib4","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1093\/gerona\/glu010","article-title":"The FNIH sarcopenia project: rationale, study, description, conference recommendations and final estimates","volume":"69","author":"Studenski","year":"2014","journal-title":"J\u00a0Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.jceh.2022.06.005_bib5","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1093\/gerona\/glu023","article-title":"Cutpoints for low appendicular lean mass that identify older adults with clinically\u00a0significant weakness","volume":"69","author":"Cawthon","year":"2014","journal-title":"J\u00a0Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.jceh.2022.06.005_bib6","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1007\/s12603-018-1139-9","article-title":"International clinical practice guidelines for sarcopenia (ICFSR): screening, diagnosis, and management","volume":"22","author":"Dent","year":"2018","journal-title":"J\u00a0Nutr Health Aging"},{"key":"10.1016\/j.jceh.2022.06.005_bib7","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jamda.2019.12.012","article-title":"Asian working group for sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment","volume":"21","author":"Chen","year":"2020","journal-title":"J\u00a0Am Med Dir Assoc"},{"key":"10.1016\/j.jceh.2022.06.005_bib8","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jamda.2013.11.025","article-title":"Sarcopenia in Asia: consensus report of the Asian working group for sarcopenia","volume":"15","author":"Chen","year":"2014","journal-title":"J\u00a0Am Med Dir Assoc"},{"key":"10.1016\/j.jceh.2022.06.005_bib9","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.clnu.2016.09.004","article-title":"ESPEN guidelines on definitions and terminology of clinical nutrition","volume":"36","author":"Cederholm","year":"2017","journal-title":"Clin Nutr"},{"key":"10.1016\/j.jceh.2022.06.005_bib10","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s12603-014-0561-x","article-title":"Comparisons of sarcopenia prevalence based on different diagnostic criteria in Chinese older adults","volume":"19","author":"Wen","year":"2015","journal-title":"J\u00a0Nutr Health"},{"key":"10.1016\/j.jceh.2022.06.005_bib11","doi-asserted-by":"crossref","first-page":"883","DOI":"10.4254\/wjh.v12.i11.883","article-title":"Malnutrition in cirrhosis: more food for thought","volume":"12","author":"Chapman","year":"2020","journal-title":"World J Hepatol"},{"key":"10.1016\/j.jceh.2022.06.005_bib12","doi-asserted-by":"crossref","first-page":"251","DOI":"10.4254\/wjh.v5.i5.251","article-title":"Cirrhotic ascites review: pathophysiology, diagnosis, management","volume":"5","author":"Moore","year":"2013","journal-title":"World J Hepatol"},{"key":"10.1016\/j.jceh.2022.06.005_bib13","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.cgh.2011.08.016","article-title":"Prevalence and mechanisms of\u00a0malnutrition in patients with advanced liver disease, and nutrition management strategies","volume":"10","author":"Cheung","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2022.06.005_bib14","article-title":"A\u00a0narrative review of nutritional abnormalities, complications, and optimization in the cirrhotic patient","author":"Warner","year":"2021","journal-title":"Transl Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2022.06.005_bib15","article-title":"Role of nutrition in the management of hepatic encephalopathy in end-stage liver failure","volume":"2010","author":"Bemeur","year":"2010","journal-title":"J\u00a0Nutri Metab"},{"issue":"suppl 1","key":"10.1016\/j.jceh.2022.06.005_bib16","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s40265-018-1017-0","article-title":"Hepatic encephalopathy in cirrhosis: pathology and pathophysiology","volume":"79","author":"Butterworth","year":"2019","journal-title":"Drugs"},{"key":"10.1016\/j.jceh.2022.06.005_bib17","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.3748\/wjg.v21.i11.3197","article-title":"Hyponatremia in cirrhosis: pathophysiology and management","volume":"21","author":"John","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jceh.2022.06.005_bib18","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3350\/cmh.2019.0015","article-title":"Sarcopenia: ammonia metabolism and hepatic encephalopathy","volume":"25","author":"Jindal","year":"2019","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.jceh.2022.06.005_bib19","doi-asserted-by":"crossref","first-page":"e218","DOI":"10.1038\/emm.2015.122","article-title":"Regulation of glucose metabolism from a liver-centric perspective","volume":"48","author":"Han","year":"2016","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.jceh.2022.06.005_bib20","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.jamda.2016.04.019","article-title":"Skeletal muscle regulates metabolism via interorgan crosstalk: roles in health and disease","volume":"17","author":"Argil\u00e9s","year":"2016","journal-title":"J\u00a0Am Med Dir Assoc"},{"key":"10.1016\/j.jceh.2022.06.005_bib21","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1111\/apt.13549","article-title":"Review article: sarcopenia in cirrhosis \u2013 aetiology, implications, and potential therapeutic interventions","volume":"43","author":"Sinclair","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jceh.2022.06.005_bib22","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.3390\/cells8111423","article-title":"Metabolic signature of hepatic fibrosis: from individual pathways to systems biology","volume":"8","author":"Chang","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.jceh.2022.06.005_bib23","doi-asserted-by":"crossref","first-page":"5357","DOI":"10.3390\/ijms21155357","article-title":"Molecular mechanism contributing to malnutrition and sarcopenia in patients with liver cirrhosis","volume":"21","author":"Meyer","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jceh.2022.06.005_bib24","doi-asserted-by":"crossref","first-page":"72","DOI":"10.15430\/JCP.2019.24.2.72","article-title":"Therapeutic effects of amino acids in liver diseases: current studies and future perspectives","volume":"24","author":"Lee","year":"2019","journal-title":"J\u00a0Cancer Prev"},{"key":"10.1016\/j.jceh.2022.06.005_bib25","first-page":"30","article-title":"Hyperammonemia and proteostasis in cirrhosis","volume":"21","author":"Dasarathy","year":"2018","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/j.jceh.2022.06.005_bib26","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1002\/jcsm.12262","article-title":"Myostatin and beyond in cirrhosis: all roads lead to sarcopenia","volume":"8","author":"Dasarathy","year":"2017","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.jceh.2022.06.005_bib27","doi-asserted-by":"crossref","first-page":"293","DOI":"10.33549\/physiolres.934648","article-title":"The role of skeletal muscle in the pathogenesis of altered concentrations of branched-chain amino acids (valine, leucine, and isoleucine) in liver cirrhosis, diabetes, and other diseases","volume":"70","author":"Holecek","year":"2021","journal-title":"Physiol Res"},{"key":"10.1016\/j.jceh.2022.06.005_bib28","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.3390\/nu11122861","article-title":"Vitamin D deficiency and sarcopenia in older persons","volume":"11","author":"Remelli","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.jceh.2022.06.005_bib29","first-page":"297","article-title":"Vitamin D deficiency in patients with liver cirrhosis","volume":"29","author":"Konstantakis","year":"2016","journal-title":"Ann Gastroenterol"},{"key":"10.1016\/j.jceh.2022.06.005_bib30","doi-asserted-by":"crossref","first-page":"93","DOI":"10.7326\/0003-4819-152-2-201001190-00008","article-title":"Narrative Review: the role of leptin in human physiology: emerging clinical applications","volume":"152","author":"Kelesidis","year":"2010","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jceh.2022.06.005_bib31","first-page":"62","article-title":"Ghrelin levels in patients with liver cirrhosis","volume":"15","author":"Elaghori","year":"2019","journal-title":"Acta Endocrinol"},{"key":"10.1016\/j.jceh.2022.06.005_bib32","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1093\/ajcn\/85.3.808","article-title":"Altered postprandial glucose, insulin, leptin and ghrelin in liver cirrhosis: correlations with energy intake and resting energy expenditure","volume":"85","author":"Kalaitzakis","year":"2007","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jceh.2022.06.005_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0159142","article-title":"Serum leptin is a biomarker of malnutrition in decompensated cirrhosis","volume":"11","author":"Rachakonda","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jceh.2022.06.005_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024633","article-title":"Leptin in sarcopenic visceral obesity: possible link between adipocytes and myocytes","volume":"6","author":"Kohara","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jceh.2022.06.005_bib35","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1530\/EJE-10-0508","article-title":"Altered fasting and postprandial plasma ghrelin levels in patients with liver failure are normalized after liver transplantation","volume":"163","author":"Diz-Lois","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.jceh.2022.06.005_bib36","doi-asserted-by":"crossref","first-page":"E671","DOI":"10.1152\/ajpendo.00120.2016","article-title":"Insulin does not stimulate muscle protein synthesis during increased plasma branched-chain amino acids alone but still decreases whole body proteolysis in humans","volume":"311","author":"Everman","year":"2016","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.jceh.2022.06.005_bib37","doi-asserted-by":"crossref","first-page":"E2574","DOI":"10.1210\/jc.2014-2736","article-title":"High insulin combined with essential amino acids stimulates skeletal muscle mitochondrial protein synthesis while decreasing insulin sensitivity in healthy humans","volume":"99","author":"Robinson","year":"2014","journal-title":"J\u00a0Clin Endrocrinol Metab"},{"key":"10.1016\/j.jceh.2022.06.005_bib38","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.cmet.2017.06.010","article-title":"Insulin regulation of proteostasis and clinical implications","volume":"26","author":"James","year":"2017","journal-title":"Cell Metabol"},{"key":"10.1016\/j.jceh.2022.06.005_bib39","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1152\/physiol.00048.2018","article-title":"Hepatic insulin clearance: mechanism and physiology","volume":"34","author":"Najjar","year":"2019","journal-title":"Physiol"},{"key":"10.1016\/j.jceh.2022.06.005_bib40","doi-asserted-by":"crossref","first-page":"G1458","DOI":"10.1152\/ajpgi.00389.2011","article-title":"Insulin resistance in patients with cirrhosis and portal hypertension","volume":"302","author":"Erice","year":"2012","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jceh.2022.06.005_bib41","doi-asserted-by":"crossref","first-page":"99","DOI":"10.4254\/wjh.v3.i5.99","article-title":"Insulin resistance and chronic liver disease","volume":"3","author":"Kawaguchi","year":"2011","journal-title":"Word J Hepatol"},{"key":"10.1016\/j.jceh.2022.06.005_bib42","doi-asserted-by":"crossref","first-page":"375","DOI":"10.18203\/2349-3933.ijam20181072","article-title":"Prevalence of insulin resistance in cirrhosis of liver","volume":"5","author":"Deep","year":"2018","journal-title":"Int J Adv Med"},{"key":"10.1016\/j.jceh.2022.06.005_bib43","first-page":"237","article-title":"Insulin resistance in euglycemic cirrhosis","volume":"27","author":"Goswami","year":"2014","journal-title":"Ann Gastroenterol"},{"key":"10.1016\/j.jceh.2022.06.005_bib44","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1210\/en.2006-0251","article-title":"Insulin resistance accelerates muscle protein degradation: activation of the ubiquitin-proteosome pathway by defects in muscle cell signaling","volume":"147","author":"Wang","year":"2006","journal-title":"Endocrinololgist"},{"key":"10.1016\/j.jceh.2022.06.005_bib45","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1164\/rccm.201702-0354OC","article-title":"Role of glucagon in catabolism and muscle wasting of critical illness and modulation by nutrition","volume":"196","author":"Thiessen","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jceh.2022.06.005_bib46","article-title":"Role of insulin and other related hormones in energy metabolism \u2013 a review","volume":"2","author":"Qaid","year":"2016","journal-title":"Cogent Food Agric"},{"key":"10.1016\/j.jceh.2022.06.005_bib47","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.2217\/bmm-2016-0090","article-title":"The biology of glucagon and the consequences of hyperglucagonemia","volume":"10","author":"Albrechtsen","year":"2016","journal-title":"Biomarkers Med"},{"key":"10.1016\/j.jceh.2022.06.005_bib48","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.2337\/db19-0715","article-title":"Glucagon resistance at the level of amino acid turnover in obese subjects with hepatic steatosis","volume":"69","author":"Suppli","year":"2020","journal-title":"Diabetes"},{"key":"10.1016\/j.jceh.2022.06.005_bib49","first-page":"248","article-title":"Nutrition in patients with cirrhosis","volume":"15","author":"Calmet","year":"2019","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2022.06.005_bib50","first-page":"45","article-title":"Metabolic effects of glucagon in humans","volume":"15","author":"Adeva-Andany","year":"2019","journal-title":"J\u00a0Clin Transl Endocrinol"},{"key":"10.1016\/j.jceh.2022.06.005_bib51","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/jgh.12695","article-title":"Testosterone in men with advanced liver disease: abnormalities and implications","volume":"30","author":"Sinclair","year":"2014","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2022.06.005_bib52","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.mce.2012.10.019","article-title":"Testosterone regulation of Akt\/mTORC1\/FoxO3a signaling in skeletal muscle","volume":"365","author":"White","year":"2013","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.jceh.2022.06.005_bib53","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3389\/fimmu.2019.00293","article-title":"Causes and consequences of innate immune dysfunction in cirrhosis","volume":"10","author":"Irving","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jceh.2022.06.005_bib54","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.4254\/wjh.v7.i16.1974","article-title":"Role of systemic inflammation in cirrhosis: from pathogenesis to prognosis","volume":"7","author":"Dirchwolf","year":"2015","journal-title":"World J Hepatol"},{"key":"10.1016\/j.jceh.2022.06.005_bib55","first-page":"50","article-title":"Immune dysfunction in cirrhosis","volume":"5","author":"Noor","year":"2017","journal-title":"J\u00a0Clin Transl Hepatol"},{"key":"10.1016\/j.jceh.2022.06.005_bib56","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/cld.851","article-title":"Causes of sarcopenia in liver cirrhosis","volume":"14","author":"Bojko","year":"2019","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jceh.2022.06.005_bib57","first-page":"65","article-title":"Malnutrition in liver cirrhosis: the influence of protein and sodium","volume":"5","author":"Eghtesad","year":"2013","journal-title":"Middle East J Dig Dis"},{"key":"10.1016\/j.jceh.2022.06.005_bib58","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3389\/fmed.2020.00062","article-title":"Hepatic autonomic nervous system and neurotrophic factors regulate the pathogenesis and progression of non-alcoholic fatty liver disease","volume":"7","author":"Amir","year":"2020","journal-title":"Front Med"},{"key":"10.1016\/j.jceh.2022.06.005_bib59","doi-asserted-by":"crossref","first-page":"E231","DOI":"10.1152\/ajpendo.00222.2009","article-title":"Regulation of net hepatic glycogenolysis and gluconeogenesis by epinephrine in humans","volume":"297","author":"Dufour","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.jceh.2022.06.005_bib60","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s00535-019-01605-6","article-title":"Sarcopenia in cirrhosis: from pathogenesis to interventions","volume":"54","author":"Ebadi","year":"2019","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.jceh.2022.06.005_bib61","doi-asserted-by":"crossref","first-page":"8061","DOI":"10.3748\/wjg.v20.i25.8061","article-title":"Clinical relevance of sarcopenia in patients with cirrhosis","volume":"20","author":"Montano-Loza","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jceh.2022.06.005_bib62","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/cld.1043","article-title":"The impact of frailty, sarcopenia, and malnutrition on liver transplant outcomes","volume":"17","author":"Duong","year":"2021","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jceh.2022.06.005_bib63","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/cld.900","article-title":"Association of sarcopenia and NAFLD","volume":"16","author":"Li","year":"2020","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jceh.2022.06.005_bib64","article-title":"Impact of sarcopenia on the severity of the liver damage in patients with non-alcoholic fatty liver disease","volume":"8","author":"Azevedo","year":"2022","journal-title":"Front Nutr"},{"key":"10.1016\/j.jceh.2022.06.005_bib65","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0113637","article-title":"Grip strength across the life course: normative data from twelve British Studies","volume":"9","author":"Dodds","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jceh.2022.06.005_bib66","doi-asserted-by":"crossref","DOI":"10.1186\/s40644-019-0270-0","article-title":"CT-assessed sarcopenia is a\u00a0predictive factor for both long-term and short-term outcomes in gastrointestinal oncology patients: a systematic review and meta-analysis","volume":"19","author":"Su","year":"2019","journal-title":"Cancer Imag"},{"key":"10.1016\/j.jceh.2022.06.005_bib67","first-page":"70","article-title":"Diagnostic criteria and clinical outcomes in sarcopenia research: a literature review","volume":"7","author":"Han","year":"2018","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.jceh.2022.06.005_bib68","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/oxfordjournals.aje.a009520","article-title":"Epidemiology of Sarcopenia among the elderly in New Mexico","volume":"147","author":"Baumgartner","year":"1998","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jceh.2022.06.005_bib69","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jamda.2011.01.003","article-title":"Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International Working Group on Sarcopenia","volume":"12","author":"Fielding","year":"2011","journal-title":"J\u00a0Am Med Dir Assoc"},{"key":"10.1016\/j.jceh.2022.06.005_bib70","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1046\/j.1532-5415.2003.51534.x","article-title":"Sarcopenia: alternative definitions and associations with lower extremity function","volume":"51","author":"Newman","year":"2003","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.jceh.2022.06.005_bib71","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1002\/jcsm.12732","article-title":"Validating muscle mass cutoffs of four international sarcopenia-working groups in Japanese people using DXA and BIA","volume":"12","author":"Yamada","year":"2021","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.jceh.2022.06.005_bib72","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1089\/rej.2013.1491","article-title":"Association between short physical performance battery and falls in older people: the Progetto Veneto Anziani study","volume":"17","author":"Veronese","year":"2014","journal-title":"Rejuvenation Res"},{"key":"10.1016\/j.jceh.2022.06.005_bib73","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.exger.2019.04.009","article-title":"Nutritional status and body fat mass: determinants of sarcopenia in community-dwelling older adults","volume":"122","author":"Nasimi","year":"2019","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.jceh.2022.06.005_bib74","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1111\/liv.13876","article-title":"Sarcopenic obesity in cirrhosis \u2013 the confluence of 2 prognostic titans","volume":"38","author":"Eslamparast","year":"2018","journal-title":"Liver Int"},{"key":"10.1016\/j.jceh.2022.06.005_bib75","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1017\/S002966511500169X","article-title":"Muscle loss and obesity: the health implications of sarcopenia and sarcopenic obesity","volume":"74","author":"Wannamethee","year":"2015","journal-title":"Proc Nutr Soc"},{"key":"10.1016\/j.jceh.2022.06.005_bib76","first-page":"693","article-title":"Sarcopenic obesity \u2013 definition, etiology, and consequences","volume":"11","author":"Stenholm","year":"2008","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/j.jceh.2022.06.005_bib77","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s41999-018-0134-3","article-title":"Myosteatosis: a relevant, yet poorly explored element of sarcopenia","volume":"10","author":"Zamboni","year":"2019","journal-title":"Eur Geriatr Med"},{"key":"10.1016\/j.jceh.2022.06.005_bib78","doi-asserted-by":"crossref","first-page":"963","DOI":"10.3389\/fphys.2020.00963","article-title":"Myosteatosis in the context of skeletal muscle function deficit: an interdisciplinary workshop at the National Institute on Aging","volume":"11","author":"Correa-de-Araujo","year":"2020","journal-title":"Front Physiol"},{"key":"10.1016\/j.jceh.2022.06.005_bib79","first-page":"260","article-title":"Epidemiology of myosteatosis","volume":"13","author":"Miljkovic","year":"2010","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/j.jceh.2022.06.005_bib80","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1161\/HYPERTENSIONAHA.118.10919","article-title":"Branched-chain amino acids as critical switches in health and disease","volume":"72","author":"Zhang","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.jceh.2022.06.005_bib81","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.3390\/nu10111691","article-title":"A\u00a0distinct pattern of circulating amino acids characterizes older persons with physical frailty and sarcopenia: results from the BIOSPHERE Study","volume":"10","author":"Calvani","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.jceh.2022.06.005_bib82","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1017\/S0007114514002475","article-title":"The effectiveness of leucine on muscle protein synthesis, lean body mass, and leg lean mass accretion in older people: a systematic review and meta-analysis","volume":"113","author":"Xu","year":"2015","journal-title":"Br J Nutr"},{"key":"10.1016\/j.jceh.2022.06.005_bib83","doi-asserted-by":"crossref","first-page":"788","DOI":"10.3389\/fphys.2017.00788","article-title":"mTOR as a key regulator in maintaining skeletal muscle mass","volume":"8","author":"Yoon","year":"2017","journal-title":"Front Physiol"},{"key":"10.1016\/j.jceh.2022.06.005_bib84","doi-asserted-by":"crossref","first-page":"E305","DOI":"10.21037\/jtd.2016.03.62","article-title":"Serum creatinine, a surrogate of muscle mass, predict mortality in critically ill patients","volume":"8","author":"Thongprayoon","year":"2016","journal-title":"J\u00a0Thorac Dis"},{"key":"10.1016\/j.jceh.2022.06.005_bib85","doi-asserted-by":"crossref","first-page":"250","DOI":"10.3390\/life11030250","article-title":"Emerging treatment options of sarcopenia in chronic liver disease","volume":"11","author":"Kim","year":"2021","journal-title":"Life"},{"key":"10.1016\/j.jceh.2022.06.005_bib86","doi-asserted-by":"crossref","first-page":"18162","DOI":"10.1073\/pnas.1317049110","article-title":"Hyperammonemia in cirrhosis induces transcriptional regulation of myostatin by an NF-\u03ba\u03b2 mediated mechanism","volume":"110","author":"Qiu","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jceh.2022.06.005_bib87","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3389\/fendo.2019.00255","article-title":"Osteoporosis and sarcopenia increase frailty syndrome in the elderly","volume":"10","author":"Greco","year":"2019","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.jceh.2022.06.005_bib88","first-page":"498","article-title":"Vitamin D and osteosarcopenia: an update from epidemiological studies","volume":"20","author":"Bruyere","year":"2017","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/j.jceh.2022.06.005_bib89","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.3390\/cells9071688","article-title":"Human and rodent skeletal muscles express angiotensin II type 1 receptors","volume":"9","author":"Deminice","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jceh.2022.06.005_bib90","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/MAJ.0b013e318222e620","article-title":"Angiotensin II, oxidative stress and skeletal muscle wasting","volume":"342","author":"Sukhanov","year":"2011","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.jceh.2022.06.005_bib91","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3389\/fphys.2018.00340","article-title":"Possible role of NADPH oxidase 4 in angiotensin II-induced muscle wasting in mice","volume":"9","author":"Kadoguchi","year":"2018","journal-title":"Front Physiol"},{"key":"10.1016\/j.jceh.2022.06.005_bib92","first-page":"P23823","article-title":"Angiotensin II inhibits satellite cell proliferation and prevents skeletal muscle regeneration","volume":"288","author":"Yoshida","year":"2013","journal-title":"Cell Biol"},{"key":"10.1016\/j.jceh.2022.06.005_bib93","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1161\/CIRCRESAHA.114.305393","article-title":"Angiotensin II induces skeletal muscle atrophy by activating TFEB-mediated MuRF1 expression","volume":"117","author":"Du Bois","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/j.jceh.2022.06.005_bib94","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1161\/HYPERTENSIONAHA.109.145409","article-title":"Angiotensin II type 1 and type 2 receptors regulate basal skeletal muscle microvascular volume and glucose use","volume":"55","author":"Chai","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.jceh.2022.06.005_bib95","doi-asserted-by":"crossref","first-page":"489","DOI":"10.7861\/clinmed.2020-0089","article-title":"Sarcopenia in cirrhosis: a practical overview","volume":"20","author":"Dhaliwal","year":"2020","journal-title":"Clin Med"},{"key":"10.1016\/j.jceh.2022.06.005_bib96","doi-asserted-by":"crossref","first-page":"156","DOI":"10.12998\/wjcc.v7.i2.156","article-title":"Interventions to improve sarcopenia in cirrhosis: a systematic review","volume":"7","author":"Naseer","year":"2019","journal-title":"World J Clin Cases"},{"key":"10.1016\/j.jceh.2022.06.005_bib97","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2018.06.017","article-title":"Exercise in cirrhosis: translating evidence and experience to practice","author":"Tandon","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2022.06.005_bib98","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.4254\/wjh.v7.i28.2819","article-title":"Treating morbid obesity in cirrhosis: a quest of holy grail","volume":"7","author":"Kumar","year":"2015","journal-title":"World J Hepatol"},{"key":"10.1016\/j.jceh.2022.06.005_bib99","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1177\/1756283X11401774","article-title":"Rifaximin treatment for reduction of risk of overt hepatic encephalopathy occurrence","volume":"4","author":"Flamm","year":"2011","journal-title":"Therap Adv Gastroenterol"},{"key":"10.1016\/j.jceh.2022.06.005_bib100","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.aohep.2019.06.007","article-title":"Association between sarcopenia and hepatic encephalopathy: a systematic review and meta-analysis","volume":"19","author":"Wijarnpreecha","year":"2020","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.jceh.2022.06.005_bib101","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/cld.498","article-title":"Bone disease in cirrhosis","volume":"6","author":"Patel","year":"2015","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jceh.2022.06.005_bib102","first-page":"555","article-title":"DEXA screening \u2013 are we doing too much?","volume":"61","author":"Craig","year":"2012","journal-title":"J\u00a0Fam Pract"},{"key":"10.1016\/j.jceh.2022.06.005_bib103","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.21037\/apm-20-967","article-title":"Possible sarcopenia: early screening and intervention \u2013 narrative review","volume":"9","author":"Xie","year":"2020","journal-title":"Ann Palliat Med"},{"key":"10.1016\/j.jceh.2022.06.005_bib104","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/hep.29219","article-title":"Development of a novel frailty index to predict mortality in patient with end-stage liver disease","volume":"66","author":"Lai","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2022.06.005_bib105","doi-asserted-by":"crossref","first-page":"643","DOI":"10.3904\/kjim.2016.015","article-title":"Differences among skeletal muscle mass indices derived from height-, weight-, and body mass index-adjusted models in assessing sarcopenia","volume":"31","author":"Kim","year":"2016","journal-title":"Korean J Intern Med (Engl Ed)"},{"key":"10.1016\/j.jceh.2022.06.005_bib106","doi-asserted-by":"crossref","first-page":"6491","DOI":"10.1038\/s41598-017-06831-7","article-title":"Comparisons of three different methods for defining sarcopenia: an aspect of cardiometabolic risk","volume":"7","author":"Kim","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jceh.2022.06.005_bib107","first-page":"161","article-title":"A\u00a0pilot stydt of racial differences in the current definition of sarcopenia among liver transplant candidates","volume":"79","author":"Sempokuya","year":"2020","journal-title":"Hawaii J Health Soc Welf"},{"key":"10.1016\/j.jceh.2022.06.005_bib108","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3350\/cmh.2017.0077","article-title":"Clinical usefulness of psoas muscle thickness for the diagnosis of sarcopenia in patients with liver cirrhosis","volume":"24","author":"Gu","year":"2018","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.jceh.2022.06.005_bib109","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.3346\/jkms.2014.29.9.1253","article-title":"Sarcopenia as a useful predictor for long-term mortality in cirrhotic patients with ascites","volume":"29","author":"Kim","year":"2014","journal-title":"J\u00a0Kor Med Sci"},{"key":"10.1016\/j.jceh.2022.06.005_bib110","doi-asserted-by":"crossref","first-page":"215","DOI":"10.21037\/qims-21-314","article-title":"Sarcopenia defined by psoas muscle index\u00a0independently predicts long-term survival after living donor liver transplantation in male recipients","volume":"12","author":"Tan","year":"2022","journal-title":"Quant Imag Med Surg"},{"key":"10.1016\/j.jceh.2022.06.005_bib111","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1002\/jcsm.12212","article-title":"Elevated serum myostatin level is associated with worse survival in patients with liver cirrhosis","volume":"8","author":"Nishikawa","year":"2017","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.jceh.2022.06.005_bib112","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.3390\/cancers12113347","article-title":"Serum myostatin predicts the risk of hepatocellular carcinoma in patients with alcoholic cirrhosis: a multicenter study","volume":"12","author":"Kim","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.jceh.2022.06.005_bib113","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000448247","article-title":"Oral drugs related with muscle wasting and sarcopenia: a review","volume":"99","author":"Campins","year":"2017","journal-title":"Pharmacology"},{"key":"10.1016\/j.jceh.2022.06.005_bib114","first-page":"27","article-title":"Effectiveness of metformin on weight loss in non-diabetic individuals with obesity","volume":"121","author":"Seifarth","year":"2013","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.jceh.2022.06.005_bib115","first-page":"863","article-title":"Effect of L-carnitine in patients with liver cirrhosis on energy metabolism using indirect calorimetry: a pilot study","volume":"8","author":"Sakai","year":"2016","journal-title":"J\u00a0Clin Med Res"},{"key":"10.1016\/j.jceh.2022.06.005_bib116","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3390\/nu10030349","article-title":"L-carnitine supplementation in recovery after exercise","volume":"10","author":"Fielding","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.jceh.2022.06.005_bib117","article-title":"Role of carnitine in non-alcoholic fatty liver disease and other related disease: an update","volume":"8","author":"Li","year":"2021","journal-title":"Front Med"},{"key":"10.1016\/j.jceh.2022.06.005_bib118","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3892\/br.2020.1372","article-title":"Effect of L-carnitine on health-related quality of life on patients with cirrhosis","volume":"13","author":"Sato","year":"2020","journal-title":"Biomed Rep"},{"key":"10.1016\/j.jceh.2022.06.005_bib119","doi-asserted-by":"crossref","DOI":"10.1038\/srep17535","article-title":"Evaluation of follistatin as a therapeutic in models of skeletal muscle atrophy associated with denervation and tenotomy","volume":"5","author":"Sepulveda","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.jceh.2022.06.005_bib120","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1083\/jcb.201109091","article-title":"Follistatin-mediated skeletal muscle hypertrophy is regulated by Smad3 and mTOR independently of myostatin","volume":"197","author":"Winbanks","year":"2012","journal-title":"J\u00a0Cell Biol"},{"key":"10.1016\/j.jceh.2022.06.005_bib121","doi-asserted-by":"crossref","DOI":"10.1002\/jcsm.12434","article-title":"Amelioration of muscle wasting by glucagon-like peptide-1 receptor agonist in muscle atrophy","volume":"10","author":"Hong","year":"2019","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.jceh.2022.06.005_bib122","first-page":"135","article-title":"Pharmacological perspectives in sarcopenia: a potential role for renin-angiotensin system blockers?","volume":"12","author":"Sartiani","year":"2015","journal-title":"Clin Cases Miner Bone Metab"},{"key":"10.1016\/j.jceh.2022.06.005_bib123","doi-asserted-by":"crossref","first-page":"bvaa007","DOI":"10.1210\/jendso\/bvaa007","article-title":"Angiotensin-(1-7) participates in enhanced skeletal muscle insulin sensitivity after a bout of exercise","volume":"4","author":"Echeverria-Rodriguez","year":"2020","journal-title":"J\u00a0Endocr Soc"},{"key":"10.1016\/j.jceh.2022.06.005_bib124","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1161\/HYPERTENSIONAHA.117.10406","article-title":"Angiotensin-(1-7) and vascular function","volume":"71","author":"Touyz","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.jceh.2022.06.005_bib125","doi-asserted-by":"crossref","first-page":"26239","DOI":"10.1074\/jbc.M114.585521","article-title":"Angiotensin type 2 receptor signaling in satellite cells potentiates skeletal muscle regeneration","volume":"289","author":"Yoshida","year":"2014","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jceh.2022.06.005_bib126","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12882-019-1223-3","article-title":"Angiotensin II receptor blockade is associated with preserved muscle strength in chronic hemodialysis patients","volume":"20","author":"Lin","year":"2019","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.jceh.2022.06.005_bib127","first-page":"1347","article-title":"Sarcopenia in chronic kidney disease what have we learned so far?","volume":"34","author":"Sabatino","year":"2021","journal-title":"J\u00a0Nephrol"},{"key":"10.1016\/j.jceh.2022.06.005_bib128","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1093\/ageing\/afn124","article-title":"ACE inhibitors for sarcopenia \u2013 as good as exercise training?","volume":"37","author":"Witham","year":"2008","journal-title":"Age Ageing"},{"key":"10.1016\/j.jceh.2022.06.005_bib129","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.jamda.2020.07.012","article-title":"Effect of angiotensin system inhibitors on physical performance in older people \u2013 a systematic review and meta-analysis","volume":"22","author":"Caulfield","year":"2021","journal-title":"J\u00a0Am Med Dir Assoc"},{"key":"10.1016\/j.jceh.2022.06.005_bib130","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/gerona\/glt142","article-title":"Do ACE inhibitors improve the response to exercise training in functionally impaired older adults? A randomized controlled trial","volume":"69","author":"Sumukadas","year":"2014","journal-title":"J\u00a0Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.jceh.2022.06.005_bib131","article-title":"Effect of perindopril or leucine on physical performance in older people with sarcopenia: the LACE randomized controlled trial","author":"Achison","year":"2022","journal-title":"J\u00a0Cachexia Sarcopenia"},{"key":"10.1016\/j.jceh.2022.06.005_bib132","doi-asserted-by":"crossref","first-page":"192","DOI":"10.5534\/wjmh.180001","article-title":"Testosterone and sarcopenia","volume":"36","author":"Shin","year":"2018","journal-title":"World J Mens Health"}],"container-title":["Journal of Clinical and Experimental Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688322001542?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688322001542?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T06:08:29Z","timestamp":1760854109000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0973688322001542"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":132,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S0973688322001542"],"URL":"https:\/\/doi.org\/10.1016\/j.jceh.2022.06.005","relation":{},"ISSN":["0973-6883"],"issn-type":[{"value":"0973-6883","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sarcopenia in the Cirrhotic Patient: Current Knowledge and Future Directions","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical and Experimental Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jceh.2022.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}